Leading the Charge for the Morning-After Pill
by Loolwa Khazzoom • February 7, 2010 • Health & Wellness , The Boston Globe
Though the Food and Drug Administration’s official rejection stated that the morning-after pill had not been tested on enough girls under 16, reproductive-rights organizations and activists — including Annie Tummino of Middleborough, MA — assert that the real reason the FDA rejected over-the-counter status was pressure from the Bush administration. This article provides an investigative report on Tummino’s lawsuit against the FDA.
Loolwa Khazzoom has worked with 
